Resumo

MARTINEZ SANCHEZ, Lina Maria et al. Residual minimal disease: breaking the paradigm of complete remission. Rev Cubana Hematol Inmunol Hemoter [online]. 2018, vol.34, n.1, pp. 21-32. ISSN 1561-2996.

Hematological malignancies constitute a heterogeneous group of conditions. Residual minimal disease (RMS) refers to the presence of haematological malignancy in patients who are in remission if conventional pathological analyzes are used. RMS has been shown to have prognostic significance in conditions such as: acute myeloid leukemia, chronic myeloid leukemia, multiple myeloma, and acute and chronic lymphoblastic leukemia. Ultrasensitive detection of this condition could allow a better risk stratification and open opportunities for early therapeutic interventions. In the following article there will be a brief review about the prognostic importance of RMS in different hematologic malignancies.

Palavras-chave : neoplasm residual; flow cytometry; prognosis.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )